KYNTRA BIO, INC. (KYNB)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $2k
- Sep 1 · Routine
- Form 4 sales
- 334
- On record
- Form 144 notices
- 18
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planJun 23, 2023 2023
Sold 791 shares at $16.53 ($13k)
Wettig Thane, Chief Commercial Officer
No 10b5-1 planSold 0.7% of holdings ($1.8M position)108,261 shares left0.9x usual sizeFollows a Form 144Filing
- 2 Form 4 saleNo planJul 7, 2023 +14 days
Sold 1,880 shares at $2.80 ($5k)
Conterno Enrique A, Chief Executive Officer
No 10b5-1 planSold 0.5% of holdings ($1.1M position)374,722 shares left0.7x usual sizeFiling
- 3 Form 144 noticeNoticeJul 11, 2023 +4 days
Filed to sell 2,000 shares ($5k)
Henderson Jeffrey William, Director
10b5-1 planFiling
- 4 Form 4 saleRoutineJul 11, 2023 same day
Sold 2,000 shares at $2.69 ($5k)
Henderson Jeffrey William, Director
10b5-1 planSold 5.7% of holdings ($94k position)32,866 shares leftFollows a Form 144Filing
- 5 Form 144 noticeNoticeAug 4, 2023 +24 days
Filed to sell 2,000 shares ($4k)
Henderson Jeffrey William, Director
10b5-1 planFiling
- 6 Form 4 saleRoutineAug 4, 2023 same day
Sold 2,000 shares at $1.91 ($4k)
Henderson Jeffrey William, Director
10b5-1 planSold 6.1% of holdings ($63k position)30,866 shares leftFollows a Form 144Filing
- 7 Form 144 noticeNoticeSep 1, 2023 +28 days
Filed to sell 2,000 shares ($2k)
Henderson Jeffrey William, Director
10b5-1 plan1x usual sizeFiling
- 8 Form 4 saleRoutineSep 1, 2023 same day
Sold 2,000 shares at $1.03 ($2k)
Henderson Jeffrey William, Director
10b5-1 planSold 6.5% of holdings ($32k position)28,866 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales, notices and lockups (352)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Sep 6, 2023 | Henderson Jeffrey William | Director | Form 4 sale | 2,000 | $2k | 6.5% | Routine | SEC |
| Sep 1, 2023 | Sep 1, 2023 | Henderson Jeffrey William | Director | Form 144 notice | 2,000 | $2k | Notice | SEC | |
| Aug 4, 2023 | Aug 8, 2023 | Henderson Jeffrey William | Director | Form 4 sale | 2,000 | $4k | 6.1% | Routine | SEC |
| Aug 4, 2023 | Aug 4, 2023 | Henderson Jeffrey William | Director | Form 144 notice | 2,000 | $4k | Notice | SEC | |
| Jul 11, 2023 | Jul 13, 2023 | Henderson Jeffrey William | Director | Form 4 sale | 2,000 | $5k | 5.7% | Routine | SEC |
| Jul 11, 2023 | Jul 11, 2023 | Henderson Jeffrey William | Director | Form 144 notice | 2,000 | $5k | Notice | SEC | |
| Jul 7, 2023 | Jul 10, 2023 | Conterno Enrique A | Chief Executive Officer | Form 4 sale | 1,880 | $5k | 0.5% | No plan | SEC |
| Jun 23, 2023 | Jun 26, 2023 | Wettig Thane | Chief Commercial Officer | Form 4 sale | 791 | $13k | 0.7% | No plan | SEC |
| Jun 23, 2023 | Jun 23, 2023 | Wettig Thane | Officer | Form 144 notice | 791 | $13k | Notice | SEC | |
| Jun 14, 2023 | Jun 15, 2023 | Chung Christine | SVP, China Operations | Form 4 sale | 12,500 | $215k | 5.0% | Routine | SEC |
| Jun 13, 2023 | Jun 13, 2023 | Chung Christine | Officer | Form 144 notice | 62,500 | $1.1M | Notice | SEC | |
| Jun 9, 2023 | Jun 9, 2023 | Brennan Aoife | Director | Form 144 notice | 4,733 | $81k | Notice | SEC | |
| Jun 9, 2023 | Jun 9, 2023 | Blaug Suzanne | Director | Form 144 notice | 8,520 | $147k | Notice | SEC | |
| Jun 9, 2023 | Jun 9, 2023 | Edwards Jeffrey L | Director | Form 144 notice | 7,889 | $136k | Notice | SEC | |
| Jun 9, 2023 | Jun 9, 2023 | Cravatt Benjamin | Director | Form 144 notice | 3,944 | $68k | Notice | SEC | |
| Jun 9, 2023 | Jun 9, 2023 | Cravatt Benjamin | Director | Form 4 sale | 3,944 | $68k | 12.1% | Routine | SEC |
| Jun 9, 2023 | Jun 9, 2023 | Brennan Aoife | Director | Form 4 sale | 4,733 | $81k | 14.5% | Routine | SEC |
| Jun 9, 2023 | Jun 9, 2023 | Blaug Suzanne | Director | Form 4 sale | 8,520 | $147k | 22.4% | Routine | SEC |
| Jun 9, 2023 | Jun 9, 2023 | Edwards Jeffrey L | Director | Form 4 sale | 7,889 | $136k | 18.8% | Routine | SEC |
| Jun 8, 2023 | Jun 9, 2023 | Ho Maykin | Director | Form 4 sale | 8,520 | $149k | 21.3% | Routine | SEC |
| Jun 8, 2023 | Jun 9, 2023 | Henderson Jeffrey William | Director | Form 4 sale | 7,000 | $122k | 16.7% | Routine | SEC |
| Jun 8, 2023 | Jun 8, 2023 | Graham Juan | Officer | Form 144 notice | 1,050 | $18k | Notice | SEC | |
| Jun 8, 2023 | Jun 8, 2023 | Henderson Jeffrey William | Director | Form 144 notice | 7,000 | $124k | Notice | SEC | |
| Jun 8, 2023 | Jun 8, 2023 | Ho Maykin | Director | Form 144 notice | 8,520 | $151k | Notice | SEC | |
| Jun 7, 2023 | Jun 9, 2023 | Schoeneck James A | Director | Form 4 sale | 7,100 | $128k | 8.8% | Routine | SEC |
| Jun 7, 2023 | Jun 9, 2023 | Wettig Thane | Chief Commercial Officer | Form 4 sale | 1,758 | $30k | 1.6% | No plan | SEC |
| Jun 7, 2023 | Jun 9, 2023 | Graham Juan | Chief Financial Officer | Form 4 sale | 1,785 | $30k | 2.4% | No plan | SEC |
| Jun 7, 2023 | Jun 9, 2023 | Chung Christine | SVP, China Operations | Form 4 sale | 3,633 | $62k | 1.4% | No plan | SEC |
| Jun 7, 2023 | Jun 9, 2023 | Eisner Mark | EVP, Chief Medical Officer | Form 4 sale | 2,042 | $35k | 1.2% | No plan | SEC |
| Jun 7, 2023 | Jun 9, 2023 | Conterno Enrique A | Chief Executive Officer | Form 4 sale | 8,897 | $152k | 2.3% | Unusual | SEC |
| Jun 7, 2023 | Jun 7, 2023 | Graham Juan | Officer | Form 144 notice | 1,406 | $24k | Notice | SEC | |
| Jun 7, 2023 | Jun 7, 2023 | Wettig Thane | Officer | Form 144 notice | 1,758 | $30k | Notice | SEC | |
| Jun 7, 2023 | Jun 7, 2023 | Eisner Mark | Officer | Form 144 notice | 2,042 | $35k | Notice | SEC | |
| Jun 7, 2023 | Jun 7, 2023 | Schoeneck James A | Director | Form 144 notice | 7,100 | $128k | Notice | SEC | |
| Jun 6, 2023 | Jun 7, 2023 | Chung Christine | Officer | Form 144 notice | 3,633 | $62k | Notice | SEC | |
| Jun 2, 2023 | Jun 5, 2023 | Eisner Mark | EVP, Chief Medical Officer | Form 4 sale | 1,090 | $21k | 0.7% | No plan | SEC |
| Jun 2, 2023 | Jun 2, 2023 | Eisner Mark | Officer | Form 144 notice | 1,090 | $21k | Notice | SEC | |
| Apr 10, 2023 | Apr 11, 2023 | Conterno Enrique A | Chief Executive Officer | Form 4 sale | 1,869 | $36k | 0.5% | No plan | SEC |
| Apr 4, 2023 | Apr 6, 2023 | Eisner Mark | Chief Medical Officer | Form 4 sale | 9,182 | $172k | 5.2% | No plan | SEC |
| Apr 4, 2023 | Apr 6, 2023 | Chung Christine | SVP, China Operations | Form 4 sale | 6,590 | $124k | 2.5% | No plan | SEC |
| Mar 23, 2023 | Mar 24, 2023 | Wettig Thane | Chief Commercial Officer | Form 4 sale | 905 | $17k | 0.8% | No plan | SEC |
| Mar 10, 2023 | Mar 10, 2023 | Chung Christine | SVP, China Operations | Form 4 sale | 15,960 | $330k | 5.8% | Plan not stated | SEC |
| Mar 10, 2023 | Mar 10, 2023 | Conterno Enrique A | Chief Executive Officer | Form 4 sale | 56,261 | $1.2M | 12.8% | Plan not stated | SEC |
| Mar 10, 2023 | Mar 10, 2023 | Eisner Mark | Chief Medical Officer | Form 4 sale | 17,503 | $361k | 9.1% | Plan not stated | SEC |
| Mar 10, 2023 | Mar 10, 2023 | Graham Juan | Chief Financial Officer | Form 4 sale | 7,661 | $157k | 9.5% | Plan not stated | SEC |
| Mar 10, 2023 | Mar 10, 2023 | Wettig Thane | Chief Commercial Officer | Form 4 sale | 13,934 | $287k | 11.1% | Plan not stated | SEC |
| Mar 2, 2023 | Mar 6, 2023 | Eisner Mark | Chief Medical Officer | Form 4 sale | 1,187 | $26k | 0.7% | Plan not stated | SEC |
| Jan 6, 2023 | Jan 10, 2023 | Conterno Enrique A | Chief Executive Officer | Form 4 sale | 1,538 | $31k | 0.5% | Plan not stated | SEC |
| Dec 23, 2022 | Dec 28, 2022 | Wettig Thane | Chief Commercial Officer | Form 4 sale | 734 | $12k | 0.8% | Plan not stated | SEC |
| Dec 12, 2022 | Dec 14, 2022 | Graham Juan | Chief Financial Officer | Form 4 sale | 2,188 | $32k | 3.9% | Plan not stated | SEC |